Cleared Special

K201792 - TRUSELECT Microcatheter

K201792 is the FDA 510(k) clearance for TRUSELECT Microcatheter by Boston Scientific Corporation. It is a Class 2 Cardiovascular device (product code KRA) cleared through the Special 510(k) pathway after a 28-day FDA review.

K201792 · Boston Scientific Corporation · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2020
Decision
28d
Days
Class 2
Risk

K201792 is an FDA 510(k) clearance for the TRUSELECT Microcatheter. Classified as Catheter, Continuous Flush (product code KRA), Class II - Special Controls.

Submitted by Boston Scientific Corporation (Maple Grove, US). The FDA issued a Cleared decision on July 28, 2020 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1210 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Boston Scientific Corporation devices

Submission Details

510(k) Number K201792 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 30, 2020
Decision Date July 28, 2020
Days to Decision 28 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
97d faster than avg
Panel avg: 125d · This submission: 28d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code KRA Catheter, Continuous Flush
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1210
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - KRA Catheter, Continuous Flush

All 127
Devices cleared under the same product code (KRA) and FDA review panel - the closest regulatory comparables to K201792.
Marathon Flow Directed Micro Catheter
K202318 · Micro Therapeutics, Inc. d/b/a ev3 Neurovascular · Sep 2020
Fountain ValveTip Infusion Catheter
K193082 · Merit Medical Systems, Inc. · Aug 2020
ClariVein IC
K201907 · Merit Medical Systems, Inc. · Aug 2020
Bendit2.7 Steerable Microcatheter
K200582 · Bend IT Technologies, Ltd. · Jun 2020
Instylla Microcatheter
K200744 · Instylla, Inc. · Apr 2020
Hereaeus Poseidon Microcatheter
K191305 · Heraeus Medical Components, LLC · Dec 2019